A mini-review-cancer energy reprogramming on drug resistance and immune response

Chengxiang Liu; Liuxin Yang; Tingting Gao; Xingxing Yuan; Ousman Bajinka; Kuanyu Wang

Translational Oncology (Nov 2024)

A mini-review-cancer energy reprogramming on drug resistance and immune response

Chengxiang Liu,
Liuxin Yang,
Tingting Gao,
Xingxing Yuan,
Ousman Bajinka,
Kuanyu Wang

Affiliations

Chengxiang Liu: School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin 150040, China; Department of Dermatology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150006, China
Liuxin Yang: School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin 150040, China
Tingting Gao: Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150006, China
Xingxing Yuan: School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin 150040, China; Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150006, China; Corresponding author at: Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, No. 33 Xidazhi Street, Nangang District, Harbin, Heilongjiang Province 150006, China.
Ousman Bajinka: School of Medicine and Allied Health Sciences, University of The Gambia, Banjul, The Gambia
Kuanyu Wang: Department of General Surgery, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China; Corresponding author at: Department of General Surgery, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, No. 26 Heping Street, Xiangfang District, Harbin, Heilongjiang Province 150040, China.

Journal volume & issue: Vol. 49
p. 102099

Abstract

Read online

With the growing interest to harness cancer metabolism and energy reprogramming, this mini review aimed to explain the metabolic programming revealing the mechanisms regarding the treatment resistance. This mini review summarized the prominent cancer metabolic reprogramming on macromolecules. In addition, metabolic reprogramming explaining immune response and treatment resistance as well as energy reprogramming mechanisms are briefly discussed. Finally, some prospects in MR for reversing cancer drug resistance are highlighted.

Published in Translational Oncology

ISSN: 1944-7124 (Print); 1936-5233 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/translational-oncology/

About the journal

Abstract

Keywords